Aptamer-modified gold nanoparticles for rapid aggregation-based detection of inflammation: an optical assay for interleukin-6.
MetadataShow full item record
Giorgi-Coll, S., Marín, M. J., Sule, O., Hutchinson, P., & Carpenter, K. (2019). Aptamer-modified gold nanoparticles for rapid aggregation-based detection of inflammation: an optical assay for interleukin-6.. Mikrochimica acta, 187 (1), 13. https://doi.org/10.1007/s00604-019-3975-7
A proof-of-concept aptamer-based optical assay is described for the determination of the immune signalling molecule interleukin-6 (IL-6), a key marker of acute inflammation. The optical assay is based on the aggregation of gold nanoparticles (AuNP) coated in two complimentary “sandwich-style” aptamers, each with different IL-6 target moieties. IL-6 will recognise the complimentary aptamer pair and bind to it causing the aggregation of the corresponding functionalised nanoparticles. The aggregation of the AuNPs after exposure to IL-6 induces a visible colour change from red to pink, with a corresponding change in the extinction maximum from 520 to 540 nm. The change in the extinction maximum can be monitored visually, or using a spectrophotometer or a plate reader. The optimal size and functionalisation method of aptamer-coated AuNP, and potential assay format were investigated using UV-Vis spectrophotometry, transmission electron microscopy, and dynamic light scattering. The optical assay was applied for detecting mouse IL-6 in a mixed protein 6 concentration range, and the detection limit (at S/N = 3) is 1.95 μg·mL-1. This study was performed as a proof-of-concept demonstration of this versatile assay design, with a view to developing a similar assay for use in clinical samples in future.
Inflammation, Gold, Interleukin-6, Biosensing Techniques, Kinetics, Aptamers, Nucleotide, Metal Nanoparticles
This work was supported by seed-corn funding from the National Institute for Health Research Brain Injury Healthcare Technology Co-operative (NIHR-HTC). SGC and KLHC are funded from the NIHR Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). PJH is funded by a NIHR Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge. The authors gratefully acknowledge Dr Giorgio Divitini (Department of Materials Science and Metallurgy, University of Cambridge) for transmission electron microscope access and assistance, and Prof Yorgo Modis and Ms Stephanie Reikine (Department of Medicine, University of Cambridge; Molecular Immunity Unit, MRC Laboratory for Molecular Biology) for dynamic light scattering access and assistance.
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Embargo Lift Date
External DOI: https://doi.org/10.1007/s00604-019-3975-7
This record's URL: https://www.repository.cam.ac.uk/handle/1810/299533
All rights reserved